ADMA News and Press, ADMA Biologics Inc From 04/28/21

Gainers: Brooklyn ImmunoTherapeutics (BTX) +44%.Uxin (UXIN) +25%.Ashford Hospitality Trust (AHT) +24%.Boxlight (BOXL) +21%.ADMA Biologics (ADMA) +18%.Clover Health Investments (CLOV) +16%.Unitil (UTL) +15%.Pitney Bowes (PBI) +15%.ClearSign Technologies (CLIR) +15%.Microvision (MVIS) ...

Gainers: ADMA Biologics (ADMA) +25%, Brooklyn ImmunoTherapeutics (BTX) +23%, Clover Health Investments (CLOV) +15%, Neptune Wellness Solutions (NEPT) +12%, Akouos (AKUS) +11%.Losers: Protalix BioTherapeutics (PLX) -40%, Benitec Bioph...

Top Penny Stocks for Your Wednesday Watchlist Making a penny stock watchlist ? There are a few things that you should consider. The first and arguably the most important is what’s going on in the world. Geopolitical and economic factors can greatly affect all industries as we...

ADMA Biologics (ADMA) +25% after receiving FDA approval for increased IVIG production scale.Akari Therapeutics (AKTX) +12% on receiving FDA fast track designation for Nomacopan.Sphere 3D Corp. (ANY) +12%.RiceBran Technologies (RIBT) +11%.Boxlight Corporation (BOXL) +11%.Calliditas T...

ADMA Biologics (ADMA) soars 23% premarket after the FDA has granted approval for its expanded manufacturing process, enabling fractionation and purification of a 4,400-liter plasma pool for the manufacture of Intravenous Immune Globulin ((IVIG)). The 4,400-liter IVIG plasma poo...

ADMA Increases Total Forecasted Plant Manufacturing Capacity from 400,000 Liters up to 600,000 Liters and Increases Total Forecasted Peak Revenues in Excess of $300 Million Enhanced Gross Margins and Cost Efficiencies Expected to be Realized Beginning Late 2021 and Accelerate Th...

RAMSEY, N.J. and BOCA RATON, Fla. and GOOSE CREEK, S.C., April 26, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics,...

ADMA Biologics Inc (NASDAQ:ADMA) traded at a new 52-week low today of $1.49. So far today approximately 1.6 million shares have been exchanged, as compared to an average 30-day volume of 2.9 million shares. There is potential upside of 14.7% for shares of ADMA Biologics Inc based on a cu...

ADMA Biologics Inc (NASDAQ:ADMA) traded today at a new 52-week low of $1.53. Approximately 1.6 million shares have changed hands today, as compared to an average 30-day volume of 2.9 million shares. In the past 52 weeks, ADMA Biologics Inc share prices are bracketed by a current low of $...

Shares of ADMA Biologics Inc (NASDAQ:ADMA) traded today at $1.56, breaking its 52-week low. This new low was reached on below average trading volume as 1.6 million shares traded hands, while the average 30-day volume is approximately 2.9 million shares. ADMA Biologics Inc is an end-to-en...